ERBB2 and breast cancer: The sample population analyzed may not be representative of all patients with HR + /HER2 − breast cancer as ODX is not always performed in cases where clinicopathological variables can predict a high or low risk of recurrence, older adult patients, patients with poor performance status, or patients who decline testing owing to financial or personal reasons.